Triptolide synergistically enhances antitumor activity of oxaliplatin in colon carcinoma in vitro and in vivo

DNA and Cell Biology

Volumn 33, Issue 7, 2014, Pages 418-425

  Liu, Yisheng ^a   Xiao, Erhui ^a   Yuan, Lin ^a   Li, Guofeng ^a  

^a HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; OXALIPLATIN; TRIPTOLIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BLOOD EXAMINATION; CANCER CELL LINE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER INHIBITION; CANCER SIZE; CELL CYCLE; CELL PROLIFERATION; CELL VIABILITY; COLON CANCER; COLON CARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENCY; DRUG POTENTIATION; DRUG STRUCTURE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; IN VIVO STUDY; KIDNEY; LIVER; MALE; MOUSE; MTT ASSAY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; TREATMENT DURATION; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BETA CATENIN; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; DITERPENES; DRUG SYNERGISM; EPOXY COMPOUNDS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE; MOLECULAR STRUCTURE; ORGANOPLATINUM COMPOUNDS; PHENANTHRENES; PROTEIN TRANSPORT;

EID: 84903278893     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2014.2356     Document Type: Article

References (34)

1. Bernas, T., and Dobrucki, J. (2002). Mitochondrial and nonmitochondrial reduction of MTT: interaction of MTT with TMRE, JC-1, and NAO mitochondrial fluorescent probes. Cytometry 47, 236-242.
2. Borja-Cacho, D., Yokoyama, Y., Chugh, R.K., Mujumdar, N.R., Dudeja, V., Clawson, K.A., et al. (2010). TRAIL and triptolide: an effective combination that induces apoptosis in pancreatic cancer cells. J Gastrointest Surg 14, 252-260.
3. Capaldi, M., Ricci, G., Bertolini, R., Alessandroni, L., Di Castro, A., Saraco, E., et al. (2011). Colon cancer adrenal metastasis: case report and review of the literature. G Chir 32, 361-363.
4. Chen, R.H., and Tian, Y.J. (2013). Enhanced anti-tumor efficacy of aspirin combined with triptolide in cervical cancer cells. Asian Pac J Cancer Prev 14, 3041-3044.
5. Cirocchi, R., Farinella, E., Trastulli, S., Desiderio, J., Listorti, C., Boselli, C., et al. (2013). Safety and efficacy of endoscopic colonic stenting as a bridge to surgery in the management of intestinal obstruction due to left colon and rectal cancer: a systematic review and meta-analysis. Surg Oncol 22, 14-21.
6. El Fajoui, Z., Toscano, F., Jacquemin, G., Abello, J., Scoazec, J.Y., Micheau, O., et al. (2011). Oxaliplatin sensitizes human colon cancer cells to TRAIL through JNK-dependent phosphorylation of Bcl-xL. Gastroenterology 141, 663-673.
7. Fang, W., Peng, F., Yi, T., Zhang, C., Wan, C., Xu, H., et al. (2012). Biological activity and safety of Tripterygium extract prepared by sodium carbonate extraction. Molecules 17, 11113-11123.
8. Graziose, R., Lila, M.A., and Raskin, I. (2010). Merging traditional Chinese medicine with modern drug discovery technologies to find novel drugs and functional foods. Curr Drug Discov Technol 7, 2-12.
9. Hua, H., Chen, W., Shen, L., Sheng, Q., and Teng, L. (2013). Honokiol augments the anti-cancer effects of oxaliplatin in colon cancer cells. Acta Biochim Biophys Sin (Shanghai) 45, 773-779.
10. Klawitter, M., Quero, L., Klasen, J., Liebscher, T., Nerlich, A., Boos, N., et al. (2012). Triptolide exhibits anti-inflammatory, anti-catabolic as well as anabolic effects and suppresses TLR expression and MAPK activity in IL-1beta treated human intervertebral disc cells. Eur Spine J 21 Suppl 6, S850-S859.
11. Li, W., Liu, Y., Li, X.X., Yu, Y., Wu, J.J., Wang, Q., et al. (2011). MAPKs are not involved in triptolide-induced cell growth inhibition and apoptosis in prostate cancer cell lines with different p53 status. Planta Med 77, 27-31.
12. Lin, Y.L., Liau, J.Y., Yu, S.C., Ou, D.L., Lin, L.I., Tseng, L.H., et al. (2012). KRAS mutation is a predictor of oxaliplatin sensitivity in colon cancer cells. PLoS One 7, e50701.
13. Liu, J., Shen, M., Yue, Z., Yang, Z., Wang, M., Li, C., et al. (2012a). Triptolide inhibits colon-rectal cancer cells proliferation by induction of G1 phase arrest through upregulation of p21. Phytomedicine 19, 756-762.
14. Liu, Y., and Cui, Y.F. (2013). Synergism of cytotoxicity effects of triptolide and artesunate combination treatment in pancreatic cancer cell lines. Asian Pac J Cancer Prev 14, 5243- 5248.
15. Liu, Y., Song, F., Wu, W.K., He, M., Zhao, L., Sun, X., et al. (2012b). Triptolide inhibits colon cancer cell proliferation and induces cleavage and translocation of 14-3-3 epsilon. Cell Biochem Funct 30, 271-278.
16. Liu, Z., Ma, L., and Zhou, G.B. (2011). The main anticancer bullets of the Chinese medicinal herb, thunder god vine. Molecules 16, 5283-5297.
17. Lou, Y.J., and Jin, J. (2004). Triptolide down-regulates bcr-abl expression and induces apoptosis in chronic myelogenous leukemia cells. Leuk Lymphoma 45, 373-376. (Pubitemid 38181443)
18. Qiu, D., and Kao, P.N. (2003). Immunosuppressive and antiinflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook. f. Drugs R D 4, 1-18.
19. Sharif, S., and O'Connell, M.J. (2012). Gene signatures in stage II colon cancer: a clinical review. Curr Colorectal Cancer Rep 8, 225-231.
20. Shimada, Y. (2012). [II. Postoperative adjuvant chemotherapy for colon cancer. 2. Oxaliplatin combination does not help better treatment outcome]. Gan To Kagaku Ryoho 39, 1646- 1649.
21. Shiragami, R., Murata, S., Kosugi, C., Tezuka, T., Yamazaki, M., Hirano, A., et al. (2013). Enhanced antitumor activity of cerulenin combined with oxaliplatin in human colon cancer cells. Int J Oncol 43, 431-438.
22. Soyer, P., Hamzi, L., Sirol, M., Duchat, F., Dray, X., Hristova, L., et al. (2012). Colon cancer: comprehensive evaluation with 64-section CT colonography using water enema as intraluminal contrast agent-a pictorial review. Clin Imaging 36, 113-125.
23. Sylvester, P.W. (2011). Optimization of the tetrazolium dye (MTT) colorimetric assay for cellular growth and viability. Methods Mol Biol 716, 157-168.
24. Tan, B.J., Tan, B.H., and Chiu, G.N. (2011). Effect of triptolide on focal adhesion kinase and survival in MCF-7 breast cancer cells. Oncol Rep 26, 1315-1321.
25. Telang, N., and Katdare, M. (2011). Preclinical in vitro models from genetically engineered mice for breast and colon cancer (Review). Oncol Rep 25, 1195-1201.
26. Timme, C.R., Gruidl, M., and Yeatman, T.J. (2013). Gammasecretase inhibition attenuates oxaliplatin-induced apoptosis through increased Mcl-1 and/or Bcl-xL in human colon cancer cells. Apoptosis 18, 1163-1174.
27. Tong, X., Zheng, S., Jin, J., Zhu, L., Lou, Y., and Yao, H. (2007). Triptolide inhibits cyclooxygenase-2 and inducible nitric oxide synthase expression in human colon cancer and leukemia cells. Acta Biochim Biophys Sin (Shanghai) 39, 89-95.
28. Wang, Z., Jin, H., Xu, R., Mei, Q., and Fan, D. (2009). Triptolide downregulates Rac1 and the JAK/STAT3 pathway and inhibits colitis-related colon cancer progression. Exp Mol Med 41, 717-727.
29. Wei, Y.S., and Adachi, I. (1991). Inhibitory effect of triptolide on colony formation of breast and stomach cancer cell lines. Zhongguo Yao Li Xue Bao 12, 406-410.
30. Wen, H.L., Liang, Z.S., Zhang, R., and Yang, K. (2013). Antiinflammatory effects of triptolide improve left ventricular function in a rat model of diabetic cardiomyopathy. Cardiovasc Diabetol 12, 50.
31. Wong, K.F., Chan, J.K., Chan, K.L., Tam, P., Yang, D., Fan, S.T., et al. (2008). Immunochemical characterization of the functional constituents of Tripterygium wilfordii contributing to its anti-inflammatory property. Clin Exp Pharmacol Physiol 35, 55-59. (Pubitemid 350197680)
32. Wu, P.P., Liu, K.C., Huang, W.W., Ma, C.Y., Lin, H., Yang, J.S., et al. (2011). Triptolide induces apoptosis in human adrenal cancer NCI-H295 cells through a mitochondrialdependent pathway. Oncol Rep 25, 551-557.
33. Yang, S.W., Wang, W., Xie, X.Y., Zhu, W.P., and Li, F.Q. (2011). In vitro synergistic cytotoxic effect of triptolide combined with hydroxycamptothecin on pancreatic cancer cells. Am J Chin Med 39, 121-134.
34. Zhou, G.X., Ding, X.L., Huang, J.F., Zhang, H., Wu, S.B., Cheng, J.P., et al. (2008). Apoptosis of human pancreatic cancer cells induced by Triptolide. World J Gastroenterol 14, 1504-1509. (Pubitemid 351460162)